Showing results (321-330 of 398) with videos related to

Sort By:
Pageof 40
Cancer Research and Treatment|October 5, 2018
Comparison of the 7th and the 8th AJCC Staging System for Non-metastatic D2-Resected Lymph Node-Positive Gastric Cancer Treated with Different Adjuvant ProtocolsJeong Il Yu, Do Hoon Lim, Jeeyun Lee, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|September 5, 2014
Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancerTaroh Satoh, Kyung Hee Lee, Sun Young Rha, et al.
Anti-Cancer Drugs|October 16, 2009
Definitive chemoradiation therapy with capecitabine in locally advanced pancreatic cancerHyo Song Kim, Seong Yoon Yi, Hyun Jung Jun, et al.
Oncotarget|May 7, 2017
Tissue recommendations for precision cancer therapy using next generation sequencing: a comprehensive single cancer center's experiencesMinho Cho, Soomin Ahn, Mineui Hong, et al.
International Journal of Clinical Oncology|January 21, 2026
Pan-Asian subgroup analysis of EV-302/KEYNOTE-A39: a phase 3 study to evaluate enfortumab vedotin and pembrolizumab in patients with untreated advanced urothelial carcinomaEiji Kikuchi, Michiel S Van der Heijden, Begoña P Valderrama, et al.
European Urology|September 15, 2023
Avelumab First-line Maintenance for Advanced Urothelial Carcinoma: Analysis from JAVELIN Bladder 100 by Duration of First-line Chemotherapy and Interval Before MaintenanceSrikala S Sridhar, Thomas Powles, Miguel Á Climent Durán, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 12, 2021
Phase I Study of Ceralasertib (AZD6738), a Novel DNA Damage Repair Agent, in Combination with Weekly Paclitaxel in Refractory CancerSeung Tae Kim, Simon A Smith, Peter Mortimer, et al.
Therapeutic Advances in Medical Oncology|June 16, 2020
First-in-human phase I trial of anti-hepatocyte growth factor antibody (YYB101) in refractory solid tumor patientsSeung Tae Kim, Jung Yong Hong, Se Hoon Park, et al.
Frontiers in Oncology|May 16, 2022
A Retrospective Study of First-Line Therapy Involving Immune Checkpoint Inhibitors in Patients With Poor Risk Metastatic Renal Cell CarcinomaHyunji Jo, Joohyun Hong, Hongsik Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2008
Are there any ethnic differences in molecular predictors of erlotinib efficacy in advanced non-small cell lung cancer?Myung-Ju Ahn, Byeong-Bae Park, Jin Seok Ahn, et al.
Pageof 40